Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
87,463,202
-
Shares change
-
+4,399,534
-
Total reported value, excl. options
-
$2,768,171,136
-
Value change
-
+$131,977,881
-
Put/Call ratio
-
30%
-
Number of buys
-
104
-
Number of sells
-
-89
-
Price
-
$31.65
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q3 2018
241 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q3 2018.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87,463,202 shares
of 183,255,226 outstanding shares and own 48% of the company stock.
Largest 10 shareholders include FMR LLC (9,589,513 shares), Vanguard Group Inc (6,193,249 shares), TANG CAPITAL MANAGEMENT LLC (5,950,826 shares), FRANKLIN RESOURCES INC (5,858,276 shares), JANUS HENDERSON GROUP PLC (5,426,991 shares), BAKER BROS. ADVISORS LP (5,025,298 shares), BlackRock Inc. (4,780,799 shares), WELLINGTON MANAGEMENT GROUP LLP (4,613,317 shares), STATE STREET CORP (3,249,484 shares), and FIL Ltd (3,063,383 shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.